Gherardo Baudo. Development and characterization of biomimetics nanoparticles encapsulating ponatinib, a multi-targeted tyrosine-kinase inhibitor, for the treatment of the Osteosarcoma, a type of bone cancer. Rel. Danilo Demarchi. Politecnico di Torino, Corso di laurea magistrale in Ingegneria Biomedica, 2020